The U.S. Food and Drug Administration has asked Roche to recruit a significant number of patients at primary care facilities or family doctors, which has made the trial 'a huge undertaking' because the rate of Alzheimer's among those seeking initial help for dementia is as yet uncertain.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/4KJG0vf
No comments:
Post a Comment